MPH Health Care Future Growth
Future criteria checks 0/6
MPH Health Care's revenue and earnings are forecast to decline at 60.2% and 65.7% per annum respectively while EPS is expected to decline by 152.5% per annum.
Key information
-65.7%
Earnings growth rate
-152.5%
EPS growth rate
| Pharmaceuticals earnings growth | 21.6% |
| Revenue growth rate | -60.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Dec 2024 |
Recent future growth updates
Recent updates
If You Had Bought MPH Health Care's (ETR:93M) Shares A Year Ago You Would Be Down 28%
Aug 10
What Type Of Returns Would MPH Health Care's(ETR:93M) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Aug 10We Think MPH Health Care's (ETR:93M) Statutory Profit Might Understate Its Earnings Potential
Jul 06
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 43 | 39 | 12 | -2 | 1 |
| 12/31/2024 | 81 | 76 | 11 | -3 | 1 |
| 6/30/2024 | 118 | 119 | -1 | -1 | N/A |
| 3/31/2024 | 76 | 75 | -2 | -2 | N/A |
| 12/31/2023 | 34 | 30 | -2 | -2 | N/A |
| 9/30/2023 | 33 | 40 | -1 | -1 | N/A |
| 6/30/2023 | 31 | 50 | -1 | -1 | N/A |
| 3/31/2023 | 31 | 39 | 0 | 0 | N/A |
| 12/31/2022 | 31 | 29 | 0 | 0 | N/A |
| 9/30/2022 | 10 | -20 | -1 | -1 | N/A |
| 6/30/2022 | -11 | -68 | -1 | -1 | N/A |
| 3/31/2022 | 1 | -39 | -1 | -1 | N/A |
| 12/31/2021 | 14 | -9 | -1 | -1 | N/A |
| 9/30/2021 | 18 | -12 | -1 | -1 | N/A |
| 6/30/2021 | 22 | -14 | -1 | -1 | N/A |
| 3/31/2021 | 13 | -42 | -2 | -2 | N/A |
| 12/31/2020 | 3 | -70 | -3 | -3 | N/A |
| 9/30/2020 | 20 | -37 | -2 | -2 | N/A |
| 6/30/2020 | 38 | -3 | -1 | -1 | N/A |
| 3/31/2020 | 39 | 4 | -1 | -1 | N/A |
| 12/31/2019 | 41 | 11 | -1 | -1 | N/A |
| 9/30/2019 | 19 | -13 | 0 | 0 | N/A |
| 6/30/2019 | -3 | -37 | 1 | 1 | N/A |
| 3/31/2019 | 21 | 0 | 3 | 3 | N/A |
| 12/31/2018 | 45 | 37 | 5 | 5 | N/A |
| 9/30/2018 | 64 | 63 | 1 | 1 | N/A |
| 6/30/2018 | 84 | 90 | -2 | -2 | N/A |
| 3/31/2018 | 59 | 61 | N/A | -1 | N/A |
| 12/31/2017 | 34 | 32 | N/A | 1 | N/A |
| 9/30/2017 | 22 | 45 | N/A | 0 | N/A |
| 6/30/2017 | 10 | 58 | N/A | 0 | N/A |
| 3/31/2017 | 10 | 69 | N/A | -3 | N/A |
| 12/31/2016 | 9 | 80 | N/A | -5 | N/A |
| 9/30/2016 | 83 | 90 | N/A | -2 | N/A |
| 6/30/2016 | 156 | 100 | N/A | 1 | N/A |
| 3/31/2016 | 210 | 91 | N/A | 1 | N/A |
| 12/31/2015 | 263 | 83 | N/A | 0 | N/A |
| 9/30/2015 | 239 | 43 | N/A | 1 | N/A |
| 6/30/2015 | 214 | 3 | N/A | 3 | N/A |
| 3/31/2015 | 217 | 4 | N/A | 1 | N/A |
| 12/31/2014 | 219 | 5 | N/A | 0 | N/A |
| 9/30/2014 | 226 | 6 | N/A | -3 | N/A |
| 6/30/2014 | 232 | 7 | N/A | -6 | N/A |
| 3/31/2014 | 229 | 7 | N/A | -5 | N/A |
| 12/31/2013 | 227 | 6 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).
Earnings vs Market: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).
High Growth Earnings: 93M1's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 93M1's revenue is expected to decline over the next 3 years (-60.2% per year).
High Growth Revenue: 93M1's revenue is forecast to decline over the next 3 years (-60.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 93M1's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 14:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MPH Health Care AG is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Acklin | First Berlin Equity Research GmbH |
| Cosmin Filker | GBC AG |
| Thomas Wissler | Hauck Aufhäuser Investment Banking |